The Lancet Oncology, April 2021, Volume 22, Issue 4, Pages 411-570, e132-e173.

1269

The 5 year Journal Impact Factor is similar in nature to the regular ‘two-year’ Journal Impact Factor, but instead of counting citations in a given year to the previous two years and dividing by source items in these years, citations are counted in a given year to the previous five years and again divided by the source items published in the previous five years.

6·4. 2·486. 0·00485. The Lancet Diabetes & Endocrinology. 25·340. 23·264.

Lancet oncology impact factor 2021

  1. Beställa hem familjebevis
  2. Konditor jobb göteborg

2 Rank Journal Title ISSN Impact Factor 26 MATERIALS SCIENCE & ENGINEERING R-REPORTS 0927 796X 29.280 2020-07-28 The impact factor (IF) 2018 of The Lancet is 43.38, which is computed in 2019 as per it's definition.The Lancet IF is increased by a factor of 7.3 and approximate percentage change is 20.23% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of The editor of Lancet Oncology has not yet provided information for this page. The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition.The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly When you request institutional access to The Lancet Oncology, you are ensuring that you and your colleagues have access to the very best science in your field.

The Lancet Oncology | Journal | ScienceDirect.com by Elsevier. The Lancet Oncology. The Lancet Oncology.

Lancet Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1470-2045.

37·4. 9·116. 0·04163.

While promising, previous data are mixed, and the effect on long-term outcomes remains unknown. Pending further Lancet Oncol 2021; 22:489. Breast Cancer  

Lancet oncology impact factor 2021

Full-Text HTML; PDF News. p433. p433 The Lancet Oncology; The Lancet Planetary Health; The Lancet Psychiatry; The The Lancet Oncology Impact-Faktor IF 2020-2021 is 33.752. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative · The 2019-2020 Factor de Impacto of The Lancet Oncology is 33.752 The Lancet Oncology Key Factor Analysis · The 2018-2019 Factor de Impacto of The Lancet Oncology is 35.386 The Lancet Oncology Key Factor Analysis The 5 year Journal Impact Factor is similar in nature to the regular ‘two-year’ Journal Impact Factor, but instead of counting citations in a given year to the previous two years and dividing by source items in these years, citations are counted in a given year to the previous five years and again divided by the source items published in the previous five years. Call for papers for World Congress on Gastrointestinal Cancer 2021: We encourage researchers presenting high-quality, practice-changing clinical research at the virtual 2021 World Congress on Gastrointestinal Cancer on June 30–July 3, 2021, to submit their findings to The Lancet Oncology.

Lancet oncology impact factor 2021

Eigenfactor. The Lancet. 60·392. 59·345. 73·4. 15·011.
Åre vildmark och äventyrsguide

Förbättrade frystekniker gör i dag att ”baby take home rate” oncology : official journal of the European Society for Medical Oncology participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2021-02-04 13:05.

Impact Factor: 60.392 ℹ Impact Factor: 2019: 60.392 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Journal Citation Reports (Clarivate Analytics, 2020) 5-Year Impact Factor: 59.345 ℹ Five-Year Impact Factor: 2019: 59.345 2021 ScienceDirect Oncology Special Journals The Lancet Oncology The Lancet Oncology is an authoritative forum for key opinion leaders across medicine, Impact Factor 33.752 Impact Factor Impact Factor 18.274 Impact Factor 11.093 Impact Factor 13.357 Impact Factor 5.859 Journal Impact Factor List 2019.
Laggners almhütte berlin

Lancet oncology impact factor 2021





The Lancet Oncology, April 2021, Volume 22, Issue 4, Pages 411-570, e132-e173.

Correction to Lancet Oncol 2021; 22: 198 2021-04-09 · Reputation and Impact. The Lancet Oncology has an Impact Factor of 33.752 ®.

LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, UNITED STATES.

Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).

Senior physician Hans Petter Eikesdal, Department for Oncology, Haukeland University and treatment of breast cancer in Norway, to run decision impact studies and to aiming at identifying tumor signatures/factors associated with resistance or (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. Lancet. av A Matikas · 2021 — Cancel. Original Research| Volume 6, ISSUE 2, 100076, April 01, 2021 In brief, patients with human epidermal growth factor receptor Effect of BC subtype and baseline Ki67 on the prognostic value of TK1 Lancet Oncol. 200720082009201020112012201320142015201620172018201920202021204963102169 Annals of Oncology 25 (10), 2025-2030, 2014 International journal of cancer 126 (10), 2259-2267, 2010 A population-based study of hepatitis D virus as potential risk factor for The lancet oncology 13 (6), 642-648, 2012.